Relationship between the ABO blood group and COVID-19 susceptibility, severity and mortality in two cohorts of patients.
Journal
Blood transfusion = Trasfusione del sangue
ISSN: 2385-2070
Titre abrégé: Blood Transfus
Pays: Italy
ID NLM: 101237479
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
01
08
2020
accepted:
17
09
2020
pubmed:
17
11
2020
medline:
10
2
2021
entrez:
16
11
2020
Statut:
ppublish
Résumé
Several articles reported the existence of an association between ABO blood groups and COVID-19 susceptibility. Group A and group O individuals showed a higher and lower risk, respectively, of becoming infected. No association was observed between ABO groups and mortality. To verify this association, we performed a retrospective study of two cohorts of patients with different demographic and clinical characteristics. A total of 854 regular blood donors were recruited for convalescent plasma donation after recovering from a mild COVID-19 infection, and a group of 965 patients more severely affected who were transfused during hospitalisation were also included. We also investigated the potential role of the different risk factors on patient outcome and death. To eliminate the confounding effect of risk factors on mortality, a propensity score analysis was performed. Blood group A and blood group O COVID-19 blood donors showed a higher and lower risk, respectively, for acquiring COVID-19. In contrast, this association was not found in the group of patients transfused during hospitalisation, probably due to the great differences in demographic and clinical characteristics between the two groups. Regarding severity, age was one of the most significant risk factors. ABO blood groups were also seen to represent important risk factors for COVID-19 severity and mortality. Mortality risk in group A individuals was significantly higher than in group O individuals (OR: 1.75, 95% CI: 1.22-2.51). The association between the ABO blood groups and the susceptibility to acquire COVID-19 infection was confirmed in the group of blood donors. ABO blood groups were also associated to COVID-19 severity and mortality in the group of patients transfused during hospitalisation. Therefore, blood groups A and O are two important factors to be considered when evaluating the prognosis of patients with COVID-19.
Sections du résumé
BACKGROUND
Several articles reported the existence of an association between ABO blood groups and COVID-19 susceptibility. Group A and group O individuals showed a higher and lower risk, respectively, of becoming infected. No association was observed between ABO groups and mortality. To verify this association, we performed a retrospective study of two cohorts of patients with different demographic and clinical characteristics.
MATERIAL AND METHODS
A total of 854 regular blood donors were recruited for convalescent plasma donation after recovering from a mild COVID-19 infection, and a group of 965 patients more severely affected who were transfused during hospitalisation were also included. We also investigated the potential role of the different risk factors on patient outcome and death. To eliminate the confounding effect of risk factors on mortality, a propensity score analysis was performed.
RESULTS
Blood group A and blood group O COVID-19 blood donors showed a higher and lower risk, respectively, for acquiring COVID-19. In contrast, this association was not found in the group of patients transfused during hospitalisation, probably due to the great differences in demographic and clinical characteristics between the two groups. Regarding severity, age was one of the most significant risk factors. ABO blood groups were also seen to represent important risk factors for COVID-19 severity and mortality. Mortality risk in group A individuals was significantly higher than in group O individuals (OR: 1.75, 95% CI: 1.22-2.51).
DISCUSSION
The association between the ABO blood groups and the susceptibility to acquire COVID-19 infection was confirmed in the group of blood donors. ABO blood groups were also associated to COVID-19 severity and mortality in the group of patients transfused during hospitalisation. Therefore, blood groups A and O are two important factors to be considered when evaluating the prognosis of patients with COVID-19.
Identifiants
pubmed: 33196417
pii: 2020.0256-20
doi: 10.2450/2020.0256-20
pmc: PMC7850930
doi:
Substances chimiques
ABO Blood-Group System
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
54-63Références
Br J Haematol. 2020 Jul;190(2):e93-e94
pubmed: 32453863
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Nat Commun. 2020 Nov 13;11(1):5761
pubmed: 33188185
Br J Haematol. 2005 Sep;130(6):954-63
pubmed: 16156865
Ann Hematol. 2020 Sep;99(9):2113-2118
pubmed: 32656591
Transfusion. 2020 Aug;60(8):1883-1884
pubmed: 32562280
Br J Haematol. 2020 Aug;190(4):e204-e208
pubmed: 32609874
Clin Chim Acta. 2020 Oct;509:220-223
pubmed: 32562665
Eur J Prev Cardiol. 2020 Sep;27(13):1436-1437
pubmed: 32343152
J Thromb Haemost. 2008 Jan;6(1):62-9
pubmed: 17973651
J Clin Invest. 2013 Mar;123(3):958-65
pubmed: 23454758
Glycobiology. 2008 Dec;18(12):1085-93
pubmed: 18818423
Br J Haematol. 2020 Jul;190(1):24-27
pubmed: 32379894
N Engl J Med. 2020 Oct 15;383(16):1522-1534
pubmed: 32558485
N Engl J Med. 2020 Jun 18;382(25):e102
pubmed: 32356626
Vox Sang. 2021 Jan;116(1):15-17
pubmed: 32965025
JAMA. 2020 Feb 4;323(5):466-467
pubmed: 31922529
Eur J Hum Genet. 2020 Jun;28(6):715-718
pubmed: 32404885
JAMA. 2005 Mar 23;293(12):1450-1
pubmed: 15784866
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264